Increasing evidence shows that statins increase the risk of new-onset diabetes mellitus, but the exact mechanism is not clearly known. Free fatty acid receptor 1 (FFA1) has been recognized to mediate insulin secretion, and pioglitazone has direct effects on glucose-stimulated insulin secretion in addition to the reversion of insulin resistance. In this study, we found that atorvastatin decreased potassium-stimulated insulin secretion and inhibited the expression of FFA1, PDX-1, and BETA2/NeuroD in INS-1 cells. Further study demonstrated that pioglitazone prevented the impairment of insulin secretion induced by atorvastatin and enhanced the expression of FFA1, PDX-1, and BETA2/NeuroD reduced by atorvastatin in INS-1 cells. In addition, the preventive effect of pioglitazone on atorvastatin-induced impairment of insulin secretion and the enhancement of the expression of PDX-1 and BETA2/NeuroD was abolished by knockdown of FFA1 using siRNA or the PLC inhibitor, U-73122, respectively. Ultimately, FFA1 may mediate the atorvastatin-induced pancreatic β-cell dysfunction and pioglitazone may ameliorate this deleterious effect through the upregulation of FFA1 expression.
The relationship between the NADPH oxidase p22phox C242T and susceptibility to ischemic stroke (IS) has been extensively studied, yet the findings from these studies remain inconsistent. To clarify this association, we conducted an updated meta-analysis of case-control studies. A comprehensive literature search of PubMed, Embase, and CNKI was performed on January 31, 2025. Studies exhibiting Hardy-Weinberg equilibrium (HWE) deviations in the control population were excluded from analysis. Pooled odds ratios (ORs) with corresponding 95 % confidence intervals (CIs) were calculated to evaluate the association across various genetic models. Our meta-analysis included 10 studies, comprising 3,422 cases and 3,410 controls. We found no significant association between the C242T polymorphism and IS susceptibility under any genetic model. Subgroup analyses stratified by ethnicity and IS type similarly revealed no significant increase in risk. Sensitivity analysis confirmed the stability of these pooled results. This updated meta-analysis suggests that the NADPH oxidase p22phox C242T polymorphism lacks a significant association with ischemic stroke risk. Nevertheless, larger and more diverse population studies are warranted to confirm these findings.